| UK Botox rules to change |
|
|
|
| Thursday, 15 November 2007 | ||
|
But following talks last month between the Nursing and Midwifery Council (NMC), the Royal College of Nursing, and the UK's Healthcare Commission, the NMC is expected to announce that the current practice of remote prescribing and administration is a breach of professional rules that could invalidate a nurse's registration. Liz Plastow, a professional advisor to the NMC, said that she believes that remote prescribing should only be carried out in "exceptional circumstances", such as when a patient would face a health risk in the absence of treatment. If the ban is put in place, it is likely to increase the cost of Botox treatment for some UK customers. Under the current practice, the cost of providing Botox treatments is lower when the procedure is carried out only by a nurse. If the new recommendations are adopted, the requirement of a doctor to be present during treatment will almost certainly increase the cost of the procedure to customers.
...
written by Sarah Deacon, December 04, 2007 I think this is a disgrace and undermining nurses capabilities. Many nurse practioners have careers in this industry and use remote consults without the dr physically present; in line with the MHRA!Where is the evidence to suggest clients are at a higher risk of adverse reactions or nurses are incompetent to safely administer this drug for cosmetic use? I agree the industry needs regulating but do strongly oppose the idea that a dr needs to be physically present for the nurse to carry out the treatment. If a dr is happy to delegate the administration to a nurse following a remote consultation then i can see no problem at all. Many thanks to the unions for their support! |
||
| < Prev | Next > |
|---|
![[أربيك]](http://www.lipo.com/websitetranslator/images/flag_ar.gif){kind=small}
